• More than 80 percent of all health system visits include an imaging exam, making radiology an essential part of healthcare diagnostics and image quality a cornerstone of medicine.
• True Definition DL is a deep learning (DL) solution that leverages a dedicated deep neural network to enhance spatial resolution and suppress artifacts, enabling high-resolution CT imaging with improved detail and efficiency.
• FDA clearance of this technology expands GE HealthCare’s expansive portfolio of AI-enabled solutions.
GE HealthCare (Nasdaq: GEHC) has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for True Definition DL, the latest addition to its growing portfolio of deep learning image reconstruction solutions for computed tomography (CT). Designed to deliver crisp, high-resolution images with exceptional sharpness, True Definition DL builds on the company’s established TrueFidelity DL and True Enhance DL technologies helping support fast scans and broader coverage across pulmonary, musculoskeletal, and inner ear imaging.
As chronic diseases continue to rise worldwide, the demand for fast, precise imaging is accelerating. The cancer burden alone is projected to increase by over 75 percent by 2050, while cardiovascular disease prevalence is expected to rise by nearly 90 percent driven by aging populations and rising risk factors placing unprecedented pressure on clinicians and diagnostic systems for early detection.
True Definition DL is designed to overcome these limitations by delivering exceptional clarity in high resolution CT imaging for bone and lung without compromising dose efficiency or acquisition speed. Its DL-driven approach enhances spatial resolution across multiple directions, integrates artifact suppression, and supports high definition (HD) mode to improve the visibility of fine anatomical structures such as small airways, pulmonary nodules, and trabecular bone patterns.
Additionally, the solution offers a 1024 matrix for high resolution display, and chest imaging achievable in under one second, empowering clinicians to see more, diagnose with greater confidence, and expand access to high resolution imaging performance across a broader range of clinical settings.
True Definition DL joins the company’s extended deep learning portfolio for CT including TrueFidelity DL and True Enhance DL which leverages dedicated Deep Neural Networks (DNN) for image reconstruction, offering clinicians around the world improved images with better detail and quality for critical insights.
Altogether, GE HealthCare’s ongoing investment in deep learning technologies available on the Revolution Apex platform andRevolution Vibe for both in-field CT upgrades and new installations supports its vision of expanding access to AI-enabled imaging across diverse care settings. By equipping facilities with fast, high-quality imaging solutions, the company aims to help healthcare providers reduce patient backlogs, increase exam capacity, and deliver more personalized care while enabling clinicians to make fast, confident diagnoses that improve patient outcomes.
